Inhibitor Therapeutics (INTI) SEC Filings & 10K Form $0.06 +0.00 (+5.18%) As of 05/22/2025 09:30 AM Eastern Add Compare Share Share SEC Filings Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Recent Inhibitor Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView05/14/20258:00 AMInhibitor Therapeutics, Inc. (Filer)Inhibitor Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 04/10/202512:30 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)Vasisht Niraj (Reporting)Form 4Statement of changes in beneficial ownership of securities 04/07/20254:21 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)Jerman Michael Allen (Reporting)Form 4Statement of changes in beneficial ownership of securities 04/07/20254:22 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)OSMAN RONALD E (Reporting)Ronald E Osman Irrevocable Trust III (Reporting)Form 4Statement of changes in beneficial ownership of securities 04/07/20254:23 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)SEARS SAMUEL P JR (Reporting)Form 4Statement of changes in beneficial ownership of securities 04/07/20254:25 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)Yanez Michelle (Reporting)Form 4Statement of changes in beneficial ownership of securities 02/19/20258:28 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)MCNULTY JAMES A (Reporting)Form 5Annual statement of changes in beneficial ownership of securities 02/19/20258:27 PMInhibitor Therapeutics, Inc. (Issuer)Inhibitor Therapeutics (Issuer)Yanez Michelle (Reporting)Form 5Annual statement of changes in beneficial ownership of securities 11/12/20245:27 AMInhibitor Therapeutics, Inc. (Filer)Inhibitor Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/06/20248:30 AMInhibitor Therapeutics, Inc. (Filer)Inhibitor Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies PRLD 10Q Form QNCX 10Q Form RANI 10Q Form SPRO 10Q Form MAAQ 10Q Form BRNS 10Q Form ACRV 10Q Form OSTX 10Q Form LTRN 10Q Form ALGS 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (OTCMKTS:INTI) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibitor Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibitor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INTI Stock Free INTI Stock Alerts